𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mcl-1 as a therapeutic target in acute myelogenous leukemia (AML)

✍ Scribed by Bose, Prithviraj; Grant, Steven

Book ID
122210933
Publisher
Elsevier
Year
2013
Tongue
English
Weight
263 KB
Volume
2
Category
Article
ISSN
2213-0489

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

[Cancer Treatment and Research] Acute My
[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Epigenetic Mechanisms in AML – A Target for Therapy
✍ Nagarajan, Lalitha πŸ“‚ Article πŸ“… 2009 πŸ› Springer New York 🌐 English βš– 489 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as

[Cancer Treatment and Research] Acute My
[Cancer Treatment and Research] Acute Myelogenous Leukemia Volume 145 || Apoptosis in Leukemias: Regulation and Therapeutic Targeting
✍ Nagarajan, Lalitha πŸ“‚ Article πŸ“… 2009 πŸ› Springer New York 🌐 English βš– 761 KB

Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as